$13.08
-0.44-3.25%
At Close: -
$12.99
-0.09-0.69%
After Hours: Aug 23, 5:29 PM EDT
15 minutes delayed
Comments
Loading...
Summit Therapeutics (SMMT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSummit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News Summary
Summit Therapeutics Stock (NASDAQ: SMMT) stock price, news, charts, stock research, profile.
| Open | $13.64 |
| Close | $13.08 |
| Volume / Avg. | 2.44M / 4.07M |
| Day Range | $12.94 - $14.25 |
| 52 Wk Range | 1.52 - 13.80 |
| Market Cap | $9.12B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 69 |
| Short Interest | 21.35% |
| Days to Cover | 8.83 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Summit Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, a...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Summit Therapeutics (SMMT) stock?
You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.
Who are Summit Therapeutics (SMMT) competitors?
Other companies in Summit Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?
Summit Therapeutics has a consensus price target of $14.33.
What is the current price for Summit Therapeutics (SMMT)?
The stock price for Summit Therapeutics (NASDAQ: SMMT) is $12.99 last updated August 23, 2024 at 5:29 PM EDT.
Does Summit Therapeutics (SMMT) pay a dividend?
There are no upcoming dividends for Summit Therapeutics.
When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?
Summit Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Summit Therapeutics (SMMT) going to split?
There is no upcoming split for Summit Therapeutics.
What sector and industry does Summit Therapeutics (SMMT) operate in?
Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.